Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Puolakka K, et al. Arthritis Rheum. 2004 Jan;50(1):55-62. doi: 10.1002/art.11436. Arthritis Rheum. 2004. PMID: 14730599 Clinical Trial.
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C. Möttönen T, et al. Among authors: puolakka k. Lancet. 1999 May 8;353(9164):1568-73. doi: 10.1016/s0140-6736(98)08513-4. Lancet. 1999. PMID: 10334255 Clinical Trial.
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T; FIN-RACo Trial Group. Korpela M, et al. Among authors: puolakka k. Arthritis Rheum. 2004 Jul;50(7):2072-81. doi: 10.1002/art.20351. Arthritis Rheum. 2004. PMID: 15248204 Clinical Trial.
How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
Kaarela K, Hakala M, Hannonen P, Kautiainen H, Korpela M, Leirisalo-Repo M, Luosujärvi R, Luukkainen R, Möttönen T, Puolakka K. Kaarela K, et al. Among authors: puolakka k. Rheumatology (Oxford). 2005 Jan;44(1):134-5; author reply 135-6. doi: 10.1093/rheumatology/keh394. Rheumatology (Oxford). 2005. PMID: 15611310 No abstract available.
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M; FIN-RACo Trial Group. Puolakka K, et al. Arthritis Rheum. 2005 Jan;52(1):36-41. doi: 10.1002/art.20716. Arthritis Rheum. 2005. PMID: 15641055 Clinical Trial.
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, Hakala M, Arkela-Kautiainen M, Luukkainen R, Leirisalo-Repo M; FIN-RACo Trial Group. Puolakka K, et al. Ann Rheum Dis. 2006 Jul;65(7):899-904. doi: 10.1136/ard.2005.045807. Epub 2005 Nov 16. Ann Rheum Dis. 2006. PMID: 16291811 Free PMC article.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page